arrow
Z

Zhaolun Cai

Sichuan University
H指数:16
被引数:1,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study

信迪利单抗联合贝伐珠单抗生物类似药IBI305和化疗作为晚期胃或胃食管结合部腺癌的一线治疗(SBAGA):一项单臂、 Ib/II期研究

2026-08-150
OAAI
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial

中国晚期胃肠道间质瘤患者中瑞普替尼与舒尼替尼的长期结局:一项2期随机临床试验的更新分析

Cancer
IF5.1
2025-12-090
OAAI
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
2024-01-014
PRE